doi: 10.1111/cas.13576 2 Alicea-TorresK.SansevieroE.GuiJ.ChenJ.VegliaF.YuQ.et al
These diseases include Diabetes, Cancer, Autism, Parkinsons Disease, Fibromyalgia, Chronic Fatigue Syndrome/ME, Hashimotos, Rheumatoid Arthritis, and many others
Targeting PCSK9 to tackle cardiovascular disease
Given the ancient origin of the Ca 2+ -based signaling, which evolutionary developed earlier than the mitochondrial apoptotic toolkit whose emergence cannot be dated back to the times earlier than eukaryogenesis and acquisition of an endosymbiotic mitochondrion, it can be assumed that the Ca 2+ toolkit takes over a key role in cell death signaling in terminally differentiated mitochondria-free erythrocytes
The sulfhydryl group donates electrons and neutralizes harmful free radicals and reactive oxygen species before they damage cells